新闻分类 Archive | Beijing Honglin Pharma. Co., Ltd.

VIPs of the Huairou District Political Consultative Conference and Huairou District Health Commission Visited Beijing Honglin

On September 9, 2021, VIPs of the Huairou District Political Consultative Conference (HDPCC) and Huairou District Health Commission visited the Beijing Honglin pharmaceutical Co..

MORE>

/ 26
09/2021
RoToFier^® Won the Bid in the 5th National Centralized Procurement of Drugs

On June 23rd, the result of the 5th Round National Governmental Bid for Centralized Procurement of Drugs was released,

MORE>

/ 24
06/2021
Beijing Honglin Amlodipine Besylate Tablet Passed the Consistency Evaluation

Recently, following the JOPOPINE® (Nefedipine Controlled-release Tablets) and RoToFier® (Glipizide Extended Release Tablets).

MORE>

/ 07
06/2021
JUPOPINE^® (Nifedipine Controlled-release Tablets) Passed the Consistency Evaluation

JUPOPINE® (Nifedipine Controlled-release Tablets), in 2010, due to the contemporary rules of naming system,

MORE>

/ 19
05/2021
VIP Guests of China Resources Pharmaceutical Group Limited Visit Beijing Honglin

On March 24th, 2021, Guests of China Resources Pharmaceutical Group Ltd.

MORE>

/ 12
05/2021
RoToFier^® Glipizide Extended Release Tablets Got the Consistency Evaluation Certified

RoToFier^® Glipizide Extended Release Tablets got the Consistency Evaluation Certified

MORE>

/ 12
05/2021
Beijing Honglin Supported Holding the Online Hypertension Academic Seminars for Rural Communities of China

In the evening of June 19th, 2020, sponsored by Beijing Honglin pharmaceutical company, the On-Line Academic Seminars for Hypertension in Rural Communities of China was held.

MORE>

/ 23
06/2020
Fighting the Epidemic, Beijing Honglin is in Action

“All for one, one for all“, in recent days, the epidemic level of new coronavirus has worried all Chinese People,

MORE>

/ 21
03/2020

News

We advocate and persue the concept of Happy & Healthy Life.

News

Notice

VIPs of the Huairou District Political Consultative Conference and Huairou District Health Commission Visited Beijing Honglin

On September 9, 2021, VIPs of the Huairou District Political Consultative Conference (HDPCC) and Huairou District Health Commission visited the Beijing Honglin pharmaceutical Co..

/ 26

09/2021

RoToFier® Won the Bid in the 5th National Centralized Procurement of Drugs

On June 23rd, the result of the 5th Round National Governmental Bid for Centralized Procurement of Drugs was released,

/ 24

06/2021

Beijing Honglin Amlodipine Besylate Tablet Passed the Consistency Evaluation

Recently, following the JOPOPINE® (Nefedipine Controlled-release Tablets) and RoToFier® (Glipizide Extended Release Tablets).

/ 07

06/2021

JUPOPINE® (Nifedipine Controlled-release Tablets) Passed the Consistency Evaluation

JUPOPINE® (Nifedipine Controlled-release Tablets), in 2010, due to the contemporary rules of naming system,

/ 19

05/2021

VIP Guests of China Resources Pharmaceutical Group Limited Visit Beijing Honglin

On March 24th, 2021, Guests of China Resources Pharmaceutical Group Ltd.

/ 12

05/2021

RoToFier® Glipizide Extended Release Tablets Got the Consistency Evaluation Certified

RoToFier® Glipizide Extended Release Tablets got the Consistency Evaluation Certified

/ 12

05/2021

Beijing Honglin Supported Holding the Online Hypertension Academic Seminars for Rural Communities of China

In the evening of June 19th, 2020, sponsored by Beijing Honglin pharmaceutical company, the On-Line Academic Seminars for Hypertension in Rural Communities of China was held.

/ 23

06/2020

Fighting the Epidemic, Beijing Honglin is in Action

“All for one, one for all“, in recent days, the epidemic level of new coronavirus has worried all Chinese People,

/ 21

03/2020

T：010-61669960/61/62/63 E：blfy@osihl.com

Beijing Yanqi Economic Development Area, Huairou District, Beijing

© var d=new Date();document.write(d.getFullYear()); Beijing Honglin Pharmaceutical Co., Ltd. all rights reserved

document.write(unescape("%3Cspan id='cnzz_stat_icon_1281400462'%3E%3C/span%3E%3Cscript src='https://v1.cnzz.com/z.js%3Fid%3D1281400462%26show%3Dpic' type='text/javascript'%3E%3C/script%3E")); Maintenance

We advocate and persue the concept of
Happy & Healthy Life.

RoToFier^® Won the Bid in the 5th National Centralized Procurement of Drugs

JUPOPINE^® (Nifedipine Controlled-release Tablets) Passed the Consistency Evaluation

RoToFier^® Glipizide Extended Release Tablets Got the Consistency Evaluation Certified

RoToFier^® Glipizide Extended Release Tablets got the Consistency Evaluation Certified

© Beijing Honglin Pharmaceutical Co., Ltd. all rights reserved

Maintenance